Hedge Fund - VenBio Select Advisor
Biomarin Pharmaceutical Inc (BMRN)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $0 | 0% | 0 | $67.28 |
| 2 | 2024 - Q4 (2024-12-31) | $96,130,125 | 1.35% | 1,462,500 | $66.98 |
| 3 | 2024 - Q3 (2024-09-30) | $143,252,074 | 2.08% | 2,038,015 | $83.59 |
| 4 | 2024 - Q2 (2024-06-30) | $375,212,059 | 4.99% | 4,557,416 | $83.25 |
| 5 | 2024 - Q1 (2024-03-31) | $381,239,100 | 4.44% | 4,365,000 | $89.52 |
| 6 | 2023 - Q4 (2023-12-31) | $414,606,000 | 5.72% | 4,300,000 | $88.47 |
| 7 | 2023 - Q3 (2023-09-30) | $340,648,000 | 5.31% | 3,850,000 | $88.98 |
| 8 | 2023 - Q2 (2023-06-30) | $346,720,000 | 4.7% | 4,000,000 | $94.11 |
| 9 | 2023 - Q1 (2023-03-31) | $383,611,800 | 5.68% | 3,945,000 | $103.67 |
| 10 | 2022 - Q4 (2022-12-31) | $367,964,387 | 5.49% | 3,555,555 | $93.88 |
| 11 | 2022 - Q3 (2022-09-30) | $301,404,000 | 5.56% | 3,555,555 | $89.04 |
| 12 | 2022 - Q2 (2022-06-30) | $272,145,000 | 5.37% | 3,284,000 | $79.62 |
| 13 | 2022 - Q1 (2022-03-31) | $233,999,000 | 4.27% | 3,035,000 | $83.67 |
| 14 | 2021 - Q4 (2021-12-31) | $247,380,000 | 4.21% | 2,800,000 | $82.51 |
| 15 | 2021 - Q3 (2021-09-30) | $144,919,000 | 2.27% | 1,875,000 | $78.90 |
| 16 | 2021 - Q2 (2021-06-30) | $137,676,000 | 2.39% | 1,650,000 | $79.27 |
| 17 | 2021 - Q1 (2021-03-31) | $124,592,000 | 2.15% | 1,650,000 | $81.69 |
| 18 | 2020 - Q4 (2020-12-31) | $144,689,000 | 2.49% | 1,650,000 | $79.28 |
| 19 | 2020 - Q3 (2020-09-30) | $133,140,000 | 1.89% | 1,750,000 | $101.18 |
| 20 | 2020 - Q2 (2020-06-30) | $228,179,000 | 4.51% | 1,850,000 | $99.39 |
| 21 | 2020 - Q1 (2020-03-31) | $163,085,000 | 5.5% | 1,930,000 | $86.16 |
| 22 | 2019 - Q4 (2019-12-31) | $169,100,000 | 4.96% | 2,000,000 | $75.53 |
| 23 | 2019 - Q3 (2019-09-30) | $164,261,000 | 6.85% | 2,437,100 | $77.02 |
| 24 | 2019 - Q2 (2019-06-30) | $181,150,000 | 6.26% | 2,115,000 | $85.55 |
| 25 | 2019 - Q1 (2019-03-31) | $99,490,000 | 4.3% | 1,120,000 | $92.68 |
| 26 | 2018 - Q4 (2018-12-31) | $115,804,000 | 6.92% | 1,360,000 | $95.13 |
| 27 | 2018 - Q3 (2018-09-30) | $132,665,000 | 6.09% | 1,368,103 | $99.82 |
| 28 | 2018 - Q2 (2018-06-30) | $152,865,000 | 5.88% | 1,622,770 | $87.57 |
| 29 | 2018 - Q1 (2018-03-31) | $138,710,000 | 6.62% | 1,710,995 | $85.82 |
| 30 | 2017 - Q4 (2017-12-31) | $106,070,000 | 6.87% | 1,189,524 | $86.95 |
| 31 | 2017 - Q3 (2017-09-30) | $55,653,000 | 4.31% | 597,972 | $88.36 |
| 32 | 2017 - Q2 (2017-06-30) | $45,482,000 | 5.74% | 500,789 | $90.98 |
| 33 | 2017 - Q1 (2017-03-31) | $51,790,000 | 6.61% | 590,000 | $88.96 |
| 34 | 2016 - Q4 (2016-12-31) | $33,136,000 | 6.69% | 400,000 | $86.00 |
| 35 | 2016 - Q3 (2016-09-30) | $38,832,000 | 6.81% | 419,712 | $94.17 |
| 36 | 2016 - Q2 (2016-06-30) | $33,685,000 | 7.48% | 432,972 | $85.01 |
| 37 | 2016 - Q1 (2016-03-31) | $22,869,000 | 7.97% | 277,272 | $81.36 |
The displayed share prices are average quarterly stock market prices.